Healthy potentially undervalued

Results

2435

Companies which are potentially undervalued and in an acceptable financial position.

2435 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	OIL	₹417.05	-2.4%	-11.2%	₹678.4b	₹531.60	10.2	8.0%	2.8%	Energy
	CEVI	SEK 141.20	12.1%	-24.3%	SEK 3.4b	SEK 179.00	25.1	15.0%	1.9%	Healthcare
	HUSQ B	SEK 38.67	-4.3%	-19.6%	SEK 22.1b	SEK 50.25	11.2	11.6%	3.2%	Capital Goods
	ADUS	US$93.87	0.8%	-18.5%	US$1.7b	US$132.69	17.2	11.1%	n/a	Healthcare
	XP	US$15.42	3.2%	-22.3%	US$8.1b	US$23.94	7.7	10.8%	1.3%	Diversified Financials
	TESB	€20.60	5.0%	-19.7%	€1.2b	€25.50	0.4	69.5%	3.6%	Materials
	FRP	UK£1.17	0.4%	-3.3%	UK£282.7m	UK£2.05	12.3	13.6%	4.6%	Diversified Financials
	AR	US$33.90	-4.9%	-21.2%	US$10.5b	US$50.15	10.9	7.2%	n/a	Energy
	INSP	US$41.12	-2.7%	-68.3%	US$1.2b	US$52.17	9.0	-14.0%	n/a	Healthcare
	SLGN	US$41.87	6.4%	-22.0%	US$4.4b	US$53.17	15.6	12.6%	2.0%	Materials
	EMBLA	DKK 26.80	0.2%	-21.2%	DKK 11.4b	DKK 33.30	20.5	11.9%	0%	Healthcare
	FLOC	US$22.56	-5.9%	28.5%	US$2.1b	US$31.56	22.1	37.4%	1.6%	Energy
	TRLV	US$9.45	-17.8%	161.0%	US$1.8b	US$19.42	1.6	124.5%	n/a	Pharmaceuticals & Biotech
	FOUR	UK£37.30	2.8%	6.7%	UK£1.0b	UK£49.23	12.2	-5.3%	4.8%	Media
	VSTM	US$4.17	10.9%	-19.7%	US$352.4m	US$16.00	7.4	51.3%	n/a	Pharmaceuticals & Biotech
	RRC	US$36.66	-6.3%	-13.9%	US$8.8b	US$47.32	9.6	3.0%	1.1%	Energy
	ARJO B	SEK 23.90	-2.4%	-25.5%	SEK 6.5b	SEK 30.00	18.5	21.3%	4.0%	Healthcare
	PHM	€68.70	-17.6%	-15.3%	€1.2b	€106.11	14.8	31.7%	1.2%	Pharmaceuticals & Biotech
	COR	US$277.09	-1.5%	-6.6%	US$54.8b	US$350.58	21.2	5.6%	0.9%	Healthcare
	PCZ	€8.62	8.4%	-8.7%	€507.7m	€14.73	0.5	20.9%	5.5%	Banks
	INF	€38.00	-1.3%	-1.3%	€265.1m	€51.24	12.7	6.2%	5.3%	Software
	HITI	CA$3.34	3.1%	11.7%	CA$310.3m	CA$7.30	0.4	170.9%	n/a	Pharmaceuticals & Biotech
	KOF	€24.75	2.3%	-25.1%	€485.5m	€37.87	8.9	2.5%	8.9%	Consumer Durables
	LKQ	US$25.02	-1.8%	-32.1%	US$6.7b	US$40.81	12.4	14.4%	4.8%	Retail

Page 1 of 68